Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

被引:0
|
作者
Caroline Cohen
Ghislaine Perrault
Guy Griebel
Philippe Soubrié
机构
[1] Sanofi-synthelabo Recherche,
来源
Neuropsychopharmacology | 2005年 / 30卷
关键词
nicotine-seeking behavior; conditioned stimuli; cannabinoid antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.
引用
收藏
页码:145 / 155
页数:10
相关论文
共 32 条
  • [1] Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal:: Reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)
    Cohen, C
    Perrault, G
    Griebel, G
    Soubrié, P
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (01) : 145 - 155
  • [2] Effects of caffeine on persistence and reinstatement of nicotine-seeking behavior in rats: Interaction with nicotine-associated cues
    Liu X.
    Jernigan C.
    Psychopharmacology, 2012, 220 (3) : 541 - 550
  • [3] SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
    Cohen, C
    Perrault, G
    Voltz, C
    Steinberg, R
    Soubrié, P
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 451 - 463
  • [4] Effects of a Neutral CB1 Antagonist on Nicotine Taking and Reinstatement of Nicotine-seeking in Rats
    Gueye, Aliou
    Pryslawsky, Yaroslaw
    Trigo, Jose M.
    Vemuri, Kiran
    Makriyannis, Alexandros
    Le Foll, Bernard
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S161 - S161
  • [5] The CB1 receptor antagonist, SR141716, reduces the motivational and dopamine-releasing effects of nicotine in rats
    Cohen, C
    Perrault, G
    Voltz, C
    Steinberg, R
    Soubrié, P
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 479 - 479
  • [6] Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats
    Fang, Qin
    Li, Fang-Qiong
    Li, Yan-Qin
    Xue, Yan-Xue
    He, Ying-Ying
    Liu, Jian-Feng
    Lu, Lin
    Wang, Ji-Shi
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (04) : 738 - 742
  • [7] Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A)
    Diergaarde, L.
    de Vries, W.
    Raaso, H.
    Schoffelmeer, A. N. M.
    De Vries, T. J.
    NEUROPHARMACOLOGY, 2008, 55 (05) : 712 - 716
  • [8] Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior
    Christine Duarte
    Richard Alonso
    Nicole Bichet
    Caroline Cohen
    Philippe Soubrié
    Marie-Hélène Thiébot
    Neuropsychopharmacology, 2004, 29 : 911 - 920
  • [9] Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior
    Duarte, C
    Alonso, R
    Bichet, N
    Cohen, C
    Soubrié, P
    Thiébot, MH
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 911 - 920
  • [10] Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist
    Järbe, TUC
    Harris, MY
    Li, C
    Liu, Q
    Makriyannis, A
    PSYCHOPHARMACOLOGY, 2004, 177 (1-2) : 35 - 45